Publications

5808 Results

Step-function covariate effects in the proportional-hazards model.

Authors
M LeBlanc;J Crowley
Journal / Conference
The Canadian Journal of Statistics 23(2):109-129
Year
1995
Research Committee(s)
Myeloma
Study Number(s)
SWOG-8229/30

Direct visualization of the clonal progression of primary cutaneous melanoma: Application of tissue microdissectio and comparative genomic hybridization.

Authors
RN Wiltshire;P Duray;ML Bittner;T Visakorpi;PS Meltzer;RJ Tuthill;LA Liotta;JM Trent
Journal / Conference
Cancer Research 55:3954-3957
Year
1995
Research Committee(s)
Melanoma
Study Number(s)
SWOG-9111 (EST-1690)

Overview analysis issues using combined androgen deprivation overview analysis as an example.

Authors
BA Blumenstein
Journal / Conference
Urologic Oncology 1:95-100
Year
1995
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8494 (INT-0036), SWOG-8894 (INT-0105) (EST-2889)

Evaluation of topotecan in resistant and relapsing multiple myeloma: A Southwest Oncology Group study.

Authors
E Kraut;J Crowley;J Wade;L Laufman;G Weiss;S Taylor;S Salmon
Journal / Conference
Blood 86(10)(Supl.1)(#726):185a
Year
1995
Research Committee(s)
Myeloma
Study Number(s)
SWOG-9237

Exploratory methods in survival analysis.

Authors
J Crowley;M LeBlanc;R Gentleman;S Salmon
Journal / Conference
IMS Lecture Notes - Monograph Series 27:55-77
Year
1995
Research Committee(s)
Myeloma
Study Number(s)
SWOG-8229/30

A study of the mechanism of IFN alfa-2b in high-risk melanoma in the ECOG/Intergroup trial E1690.

Authors
JM Kirkwood;J Sosman;M Ernstoff;M Ross;C Gerstner;J Bryant;T Whiteside;C Johnson
Journal / Conference
American Association for Cancer Research 36(#3815):641
Year
1995
Research Committee(s)
Melanoma
Study Number(s)
SWOG-9325 (EST-2690)

Recent American multicenter trials for patients with metastatic prostate cancer.

Authors
E DeAntoni;ED Crawford
Journal / Conference
Urologe (A) 34:382-388
Year
1995
Research Committee(s)
Genitourinary

CAF vs 16 week multidrug regimen as adjuvant therapy for receptor-negative, node-positive breast cancer: An Intergroup study.

Authors
J Fetting;R Gray;M Abeloff;B Fowble;T Smith;S Vail;G Durrani;L Eudey;J Henney;K Margolin;M Citron;C Osborn;C Henderson
Journal / Conference
American Society of Clinical Oncology 14(#83):96
Year
1995
Research Committee(s)
Breast
Study Number(s)
SWOG-8931 (INT-0108) (EST-3189)

Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials.

Authors
M Clarke;R Collins;J Godwin;R Gray;R Peto
Journal / Conference
New England Journal of Medicine 333(22):1444-1455
Year
1995
Research Committee(s)
Breast

Phase III randomized study of all-trans retinoic acid (ATRA) vs daunorubicin (D) and cytosine arabinoside (A) as induction therapy and ATRA vs observation as maintenance therapy for patients with previously untreated acute promyelocytic leukemia (APL).

Authors
MS Tallman;J Andersen;CA Schiffer;FR Appelbaum;JE Feusner;WG Woods;A Ogden;H Weinstein;L Shepherd;JM Rowe;PH Wiernik
Journal / Conference
Blood 86(10)(Suppl.1)(#488):125a
Year
1995
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9129 (INT-0129)